Colgate-Palmolive Company (CL) Stake Maintained by Headinvest LLC
Headinvest LLC maintained its position in shares of Colgate-Palmolive Company (NYSE:CL) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,382 shares of the company’s stock at the end of the second quarter. Headinvest LLC’s holdings in Colgate-Palmolive were worth $399,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of CL. American Beacon Advisors Inc. acquired a new stake in Colgate-Palmolive during the first quarter worth about $102,000. Advantage Investment Management LLC acquired a new stake in Colgate-Palmolive during the fourth quarter worth about $104,000. Proficio Capital Partners LLC raised its stake in Colgate-Palmolive by 16.9% in the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after buying an additional 207 shares during the period. Harbour Capital Advisors LLC acquired a new stake in Colgate-Palmolive during the first quarter worth about $121,000. Finally, AlphaMark Advisors LLC raised its stake in Colgate-Palmolive by 452.1% in the first quarter. AlphaMark Advisors LLC now owns 1,673 shares of the company’s stock worth $122,000 after buying an additional 1,370 shares during the period. 73.57% of the stock is currently owned by institutional investors and hedge funds.
Shares of Colgate-Palmolive Company (NYSE:CL) opened at 71.85 on Tuesday. The company has a market cap of $63.29 billion, a P/E ratio of 26.70 and a beta of 0.81. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The firm has a 50 day moving average price of $74.56 and a 200-day moving average price of $72.34.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter in the prior year, the business earned $0.70 earnings per share. The firm’s revenue for the quarter was down .5% on a year-over-year basis. Analysts anticipate that Colgate-Palmolive Company will post $2.92 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.23%. The ex-dividend date is Friday, July 14th. Colgate-Palmolive’s payout ratio is 59.48%.
CL has been the topic of a number of research analyst reports. Bank of America Corporation raised their target price on Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, May 31st. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $82.00 target price on the stock in a report on Friday, April 7th. Jefferies Group LLC lowered their target price on Colgate-Palmolive from $78.00 to $76.00 and set a “hold” rating on the stock in a report on Monday, May 1st. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a report on Monday, April 24th. Finally, Vetr lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price on the stock. in a report on Wednesday, May 17th. One investment analyst has rated the stock with a sell rating, thirteen have given a hold rating and three have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $75.83.
In related news, Director Richard J. Kogan sold 8,000 shares of the stock in a transaction that occurred on Monday, May 8th. The stock was sold at an average price of $71.92, for a total transaction of $575,360.00. Following the sale, the director now owns 73,065 shares of the company’s stock, valued at $5,254,834.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Patricia Verduin sold 3,833 shares of the stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $75.67, for a total value of $290,043.11. Following the sale, the insider now directly owns 53,022 shares in the company, valued at approximately $4,012,174.74. The disclosure for this sale can be found here. Insiders sold 29,666 shares of company stock worth $2,144,371 in the last ninety days. 1.02% of the stock is owned by company insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.